The company's stock and report

US personal care manufacturer Rapid Micro Biosystems (NASDAQ: RPID) today released its financial results for the Q4 and full year 2021.

The company's shares opened at $6.09 in today's trading. However, the stock closed yesterday at US$6.10. At the time of writing at 12:32AM eastern time, the company's shares are trading at $5.78 (-5.16%).

Also, the total volume of shares bought and sold so far since the start of the trading day (Volume) is 59,765 at the time of writing. The average daily trading volume in units (Avg. Volume) is 178,367.

It is worth noting that the company's share price has declined by -22,56 % over the past five days. The highest price over the last five days was US$7.48 and the lowest was US$5.65.

Company report

Rapid Micro Biosystems (RMB) reported Q4 FY2021 revenue of US$5.2mln and commercial revenue of US$4.9mln in its report.

RMB said total revenue for FY2021 is US$23.2mln and commercial revenue of US$21.6mln.

Also, the company confirmed the commercial revenue forecast for the full year 2022 in the range of US$27mln to US$32mln.

The company's commercial revenue for the full year was US$21.6mln (+54%).

Regular commercial revenue for the full year was US$7.8mln, an increase of 100%.

RMB reported that the number of client systems increased to 116 hosted systems and 84 verified systems.

It is worth noting that as at 31 December 2021, the Company had cash, cash equivalents and investments of USD 203.5mln.

Also, Regular Commercial Revenues in the Q4 were US$2.3mln, up of 91%.

The company was founded in 2006. John Wilson is the Chief Operating Officer and Jonathan Paris, Kristine Williams, Scott White are the Vice Presidents.